rcc renal cell carcinoma

RCC (Renal Cell Carcinoma) imhando yegomarara reitsvo inonyanyozivikanwa muvanhu vakuru. Nyaya ino inoongorora chirwere ichi, ichifukidza marudzi ayo, zviratidzo, kuongororwa, nzira dzokurapa, uye prognosis.Chii Renal Cell Carcinoma?Renal Cell Carcinoma (RCC), kana kuti gomarara reitsvo, rinotangira mumucheka weproximal convoluted tubule, chikamu chemachubhu maduku zvikuru ari muitsvo anosefa ropa uye anobvisa tsvina. Kunzwisisa mhando dzakasiyana uye nhanho dze RCC kwakakosha pakurapa kunoshanda. Mhando dze Renal Cell CarcinomaSeveral subtypes ye RCC zviripo, imwe neimwe iine maitiro akasiyana uye nzira dzekurapa. Mhando dzinonyanyozivikanwa dzinosanganisira:Clear Cell Renal Cell CarcinomaIyo yakanyanya kupararira subtype, inoverengera ingangoita 70% ye RCC nyaya. Inoratidzwa nemaseru anoita seakajeka kana kucheneruka pasi pemaikorosikopu nekuda kwekuwanda kwemafuta. Kunobva: American Cancer SocietyPapillary Renal Cell CarcinomaRudzi rwechipiri rwakajairika, runosanganisira 10-15% yemakesi. Papillary RCC inoratidzirwa neminwe-yakafanana nefungidziro inonzi papillae. Zvinowanzobatanidzwa nemamwe genetic mamiriro. Kune maviri makuru subtypes: Type 1 uye Type 2, ine Type 2 kazhinji ichinyanya kuita zvehasha. Chromophobe Renal Cell CarcinomaIyi subtype inomiririra inenge 5% ye RCC nyaya. Chromophobe RCC kazhinji ane fungidziro iri nani kana ichienzaniswa nesero rakajeka RCC. Masero acho akakura uye akachenuruka pane clear cell RCC masero.Kuunganidza Duct Renal Cell CarcinomaIyo isingawanzo uye ine hutsinye subtype, inoverengera isingasviki 1% yemakesi. Kuunganidza duct RCC inomuka mumatanho ekuunganidza eitsvo, ayo anotakura weti kuenda kutundira. Inowanzoonekwa pane imwe nguva uye inogona kuva yakaoma kurapa.Medullary Renal Cell CarcinomaImwe isingawanzo uye ine hutsinye subtype, inonyanya kubata vanhu vane sickle cell maitiro. Medullary RCC inowanzobatanidzwa nemigumisiro yakaipa.Zviratidzo zve Renal Cell CarcinomaMatanho ekutanga e RCC zvingasaratidza zviratidzo zvinooneka. Zvisinei, sezvo bundu rinokura, zviratidzo zvinogona kusanganisira: Ropa muweti (hematuria) Kuramba kurwadza parutivi kana musana Bundu kana kuwanda parutivi kana musana Kurasikirwa uremu kusingatsananguriki Kurasikirwa nechido chekudya Kuneta Fivha isingakonzerwi nehutachiona Anemia (kuderera kwesero dzvuku reropa)Kana ukasangana nechimwe chezviratidzo izvi, zvakakosha kuonana nachiremba kuongororwa kwakakodzera. Renal Cell CarcinomaKuongorora RCC kazhinji zvinosanganisira musanganiswa wekuongororwa kwemuviri, bvunzo dzekufungidzira, uye biopsy.Imaging MiedzoMaitiro ekufungidzira anoita basa rakakosha pakuona nekuita RCC. Miedzo yekufungidzira yakajairika inosanganisira: Computed Tomography (CT) scan: Inopa yakadzama-sectional mifananidzo yeitsvo uye akapoteredza tishu. Magnetic Resonance Imaging (MRI): Inopa zvakapfava zvinyoro zvakasiyana uye inonyanya kubatsira pakuongorora kukura kwebundu uye kuona kupararira kune zvivakwa zviri pedyo. Ultrasound: Inogona kubatsira kusiyanisa pakati pemasasi akasimba uye macysts akazadzwa nemvura muitsvo. Renal Arteriography (Angiography): Ongororo yeX-ray yetsinga dzerenal mushure mekunge dhayi yaiswa jekiseni. Inoshandiswa zvishoma kudarika CT kana MRI.BiopsyA biopsy inosanganisira kubvisa chikamu chiduku chetsvo kuti chiongororwe pasi pe microscope. A biopsy inodiwa kusimbisa kuongororwa kwe RCC uye sarudza iyo subtype. Mifananidzo-inotungamirwa mabiopsies anowanzo kuitwa uchishandisa CT kana Ultrasound kuona kwakaringana kunanga kwenzvimbo inofungidzirwa. Matanho e Renal Cell CarcinomaDanho re RCC zvinoreva kukura kwegomarara uye kuti rapararira here kune dzimwe nhengo dzemuviri. Staging yakakosha pakuona nzira yekurapa yakakodzera uye kufanotaura prognosis. Iyo TNM (Tumor, Node, Metastasis) staging system inowanzoshandiswa: T (Tumor): Inotsanangura kukura uye kukura kwebundu rekutanga. N (Node): Inoratidza kana gomarara rapararira kumalymph nodes ari pedyo. M (Metastasis): Inoratidza kana gomarara rapararira kunzvimbo dziri kure, dzakadai semapapu, mapfupa, kana uropi.Matanho anotangira paI kusvika paIV, Danho I richiva danho rekutanga uye Danho IV richiva danho repamusoro. Renal Cell CarcinomaKurapa kwe RCC zvinoenderana nezvinhu zvakati kuti, zvinosanganisira danho regomarara, utano hwemurwere hwese, uye zvaanoda. Sarudzo dzekurapa dzakajairika dzinosanganisira:KuvhiyaKubvisa bundu kunowanzo ndiko kurapwa kwekutanga kwenzvimbo RCC (Matanho I-III). Sarudzo dzekuvhiya dzinosanganisira: Chikamu Nephrectomy: Kubviswa kwebundu chete uye muganhu muduku wehutano hwakanaka. Iyi nzira inosarudzwa kana zvichiita kuchengetedza kushanda kwetsvo. Radical Nephrectomy: Kubviswa kwetsvo yese, pamwe chete nematishu akatenderedza, senge adrenal gland uye lymph nodes. Izvi zvinowanzoitika kumamota makuru kana kana nephrectomy isingakwanisike.Targeted TherapyTargeted therapies mishonga inonangana nemamorekuru ane chekuita negomarara kukura uye kurarama. Iyi mishonga inogona kushanda mukurapa kwepamusoro RCC (Stage IV) uye inogona zvakare kushandiswa mumatanho ekutanga mune mamwe mamiriro. Mienzaniso inosanganisira: VEGF Inhibitors: Sunitinib (Sutent), Sorafenib (Nexavar), Pazopanib (Votrient), Axitinib (Inlyta), Bevacizumab (Avastin) mTOR Inhibitors: Temsirolimus (Torisel), Everolimus (Afinitor)ImmunotherapyImmunotherapy mishonga inobatsira masoja emuviri kuziva nekurwisa masero egomarara. Immunotherapy yakaratidza vimbiso yakakosha mukurapa yepamusoro RCC. Mienzaniso inosanganisira: PD-1 Inhibitors: Nivolumab (Opdivo), Pembrolizumab (Keytruda) CTLA-4 Inhibitors: Ipilimumab (Yervoy) Combination Immunotherapy: Nivolumab pamwe neIpilimumabMamwe KurapaMamwe marapirwo anogona kushandiswa mune mamwe mamiriro, akadai se: Radiation Therapy: Kushandisa high-energy mwaranzi kuuraya cancer maseru. Haisi kunyanya kushandiswa RCC, asi inogona kushandiswa kurapa metastases yemapfupa kana kuderedza marwadzo. Ablation Therapies: Matekiniki akaita seradiofrequency ablation (RFA) kana cryoablation anoshandisa kupisa kana kutonhora kuparadza bundu. Izvi zvinogona kushandiswa kumamota madiki muvarwere vasiri vakanaka kuvhiyiwa. Active Surveillance: Kune mamota madiki, anononoka kukura, kutarisisa (kunyatsotarisisa) kungave sarudzo pane kurapwa nekukurumidza.Prognosis of Renal Cell CarcinomaThe prognosis of RCC zvinosiyana zvichienderana nezvakati wandei, kusanganisira danho regomarara, subtype, uye hutano hwemurwere hwese. Kukurumidza kuona uye kurapwa kwakakosha pakuvandudza mhedzisiro. Maererano ne National Cancer Institute's SEER chirongwa, iyo 5-yemakore hukama mwero wekugara kwenzvimbo RCC (gomarara risina kupararira kunze kweitsvo) yakakwirira. Nekudaro, huwandu hwekupona hunodzikira zvakanyanya kumatanho epamusoro echirwere. 5-Year Relative Survival Rates yeRenal Cell Carcinoma Stage 5-Year Relative Survival Rate Localized RCC makore mazhinji apfuura, saka huwandu hwekupona hunogona kunge hwakwira nekuda kwekufambira mberi mukurapa.Kuti uwane ruzivo rwenyanzvi uye nzira dzepamusoro dzekurapa Renal Cell Carcinoma, ongorora zvirongwa zvekutsvaga pa Shandong Baofa Cancer Research Institute, yakatsaurirwa kufambisira mberi kutarisira kenza.